Meningococcal Vaccines Market Report 2021-2031
Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is...Full DetailsPUBLISHED: 30 September 2021Anti-obesity Drugs Market Report 2021-2031
Despite a number of obstacles, the global anti-obesity drugs market is projected to grow at a significant growth over the...Full DetailsPUBLISHED: 20 September 2021Epilepsy Therapeutics Market Report 2021-2031
As governments in emerging countries are taking measures to improve healthcare, it is positively impacting the anti-epileptic drugs market growth....Full DetailsPUBLISHED: 18 August 2021Stem Cell Technologies and Applications Market Report 2021-2031
Factors such as rising prevalence of chronic and genetic diseases, increasing application areas of stem cell technologies, technological advancements, and...Full DetailsPUBLISHED: 10 August 2021OTC Drugs & Dietary Supplements Market Report 2021-2031
From a long-term perspective, the rapid growth of the mid-class economy will enhance the demand for OTC products in emerging...Full DetailsPUBLISHED: 05 August 2021Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031
We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities,...Full DetailsPUBLISHED: 21 July 2021Gene Therapy R&D Market Report 2021-2031
Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities,...Full DetailsPUBLISHED: 11 June 2021Cellular Immunotherapy Market Report 2021-2031
Increasing prevalence of cancers and rising demand for advanced therapies for cancer treatment are the major factors driving the demand...Full DetailsPUBLISHED: 08 June 2021Anti-infective Vaccines Market Report 2021-2031
The rising frequency of bacterial and viral diseases coupled with increased focus on immunisation programmes are two main reasons that...Full DetailsPUBLISHED: 01 June 2021Inactivated Vaccines Market Report 2020-2030
Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine...
Full DetailsPUBLISHED: 13 May 2021
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Antibiotics Market Report 2023-2033
The antibiotics market was valued at US$44,567.3 million in 2022 and is projected to grow at a CAGR of 4.15% during the forecast period 2023-2033.
31 January 2023
Visiongain Publishes Clinical Trial Supplies Market Report 2023-2033
The global Clinical Trial Supplies market was valued at US$ 2,617.7 million in 2022 and is projected to grow at a CAGR of 9.32% during the forecast period 2023-2033.
31 January 2023
Visiongain Publishes Meningococcal Vaccines Market Report 2023-2033
The global Meningococcal Vaccines market was valued at US$3,268.6 million in 2022 and is projected to grow at a CAGR of 6.32% during the forecast period 2023-2033.
31 January 2023
Visiongain Publishes Human Microbiome Market Report 2023-2033
The global Human Microbiome market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25% during the forecast period 2023-2033.
30 January 2023
